Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #12,131 to #12,180.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Protein pigeon homolog (1 revision)
  2. Protein precursor (1 revision)
  3. Protein purification (1 revision)
  4. Protein skimmer (1 revision)
  5. Protein subcellular localization prediction (1 revision)
  6. Protein toxicity (1 revision)
  7. Protein unc-13 homolog C (1 revision)
  8. Proteinase K (1 revision)
  9. Proteogenix (1 revision)
  10. Proteoglycan 4 (1 revision)
  11. Proteopathy (1 revision)
  12. Proterozoic (1 revision)
  13. Proteus infection epidemiology and demographics (1 revision)
  14. Proteus infection overview (1 revision)
  15. Proteus infection screening (1 revision)
  16. Prothidathion (1 revision)
  17. Prothoate (1 revision)
  18. Prothrombin complex concentrate (1 revision)
  19. Protiofate (1 revision)
  20. Protist (1 revision)
  21. Proto-oncogene (1 revision)
  22. Protocol adherence (1 revision)
  23. Protocol amendment (1 revision)
  24. Proton (1 revision)
  25. Proton radiation astronomy (1 revision)
  26. Protoporphyrinogen oxidase (1 revision)
  27. Prototaxites (1 revision)
  28. Protothecosis (1 revision)
  29. Prototheria (1 revision)
  30. Protozoan infection (1 revision)
  31. Protriptyline (patient information) (1 revision)
  32. Prout's hypothesis (1 revision)
  33. Proventil HFA overdose (1 revision)
  34. Provo Canyon School (1 revision)
  35. Proximal isovelocity surface area (1 revision)
  36. Proximal phalanges (1 revision)
  37. Proximal tubule (1 revision)
  38. Prunella vulgaris (1 revision)
  39. Prurigo (1 revision)
  40. Psc833 (1 revision)
  41. Pseudo-Hurler polydystrophy (1 revision)
  42. Pseudo Cushing's syndrome CT (1 revision)
  43. Pseudo Cushing's syndrome MRI (1 revision)
  44. Pseudo Cushing's syndrome case study one (1 revision)
  45. Pseudo Cushing's syndrome chest x ray (1 revision)
  46. Pseudo Cushing's syndrome classification (1 revision)
  47. Pseudo Cushing's syndrome cost-effectiveness of therapy (1 revision)
  48. Pseudo Cushing's syndrome epidemiology and demographics (1 revision)
  49. Pseudo Cushing's syndrome future or investigational therapies (1 revision)
  50. Pseudo Cushing's syndrome historical perspective (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)